A- A A+

Shih-Ann Chen (陳適安)

Shih-Ann Chen(陳適安)

簡介

學歷 高雄醫學大學醫學系
經歷 現職:
  1. - 迄今 國立陽明大學 醫學系內科學科 教授
  2. - 迄今 臺北榮民總醫院 副院長
經歷:
  1. 2014- 2017 臺北榮民總醫院 內科部 主任
  2. 2009- 2014 臺北榮民總醫院 心臟內科 主任
  3. - 美國凱斯西儲大學醫學系客座教授
醫療專長
  1. 心臟內科
  2. 心律不整
  3. 心臟電氣生理學
  4. 心臟電氣燒灼術
  5. 美國心電生理學會
證照
  1. 中華民國內科專科醫師
  2. 中華民國心臟專科醫師
  3. 美國心臟學會
  4. 歐洲心臟學會
語言專長
  1. 國語/英語/台語

著作

最近五年代表著作:

  1. T.F. Chao, S.H. Sung, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, K.C. Ueng, T.J. Wu, S.A. Chen*. Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation. Heart. 2011;97:225-230. (SCI)
  2. K. Suenari, Y.C. Chen, Y.H. Kao, C.C. Cheng, Y.K. Lin, Y.J. Chen*, S.A. Chen*. Discrepant electrophysiological characteristics and calcium homeostasis of left atrial anterior and posterior myocytes. Basic Res Cardiol 2011;106:65-74. (SCI).
  3. S.Y. Huang, S.L. Chang, Y.J. Lin, S.A. Chen*. Discordance of complex fractionated atrial electrograms and the dominant frequency within the superior vena cava. Heart Rhythm. 2011;8:484-485. (SCI)
  4. S.Y. Huang, Y.F. Hu, S.L. Chang, Y.J. Lin, L.W. Lo, T.C. Tuan, P.C. Lee, C.H. Li, K. Suenari, T.F. Chao, C.T. Tai, C.E. Chiang, S.A. Chen*. Gender differences of electrophysiologic characteristics in patients with accessory atrioventricular pathways. Heart Rhythm. 2011;8:571-574. (SCI)
  5. Y.F. Hu, H.I. Yeh, H.M. Tsao, C.T. Tai, Y.J. Lin, S.L. Chang, L.W. Lo, T.C. Tuan, C.H. Tzeng, S.H. Huang, Y.K. Lin, S.A. Chen*. Impact of the circulating monocyte CD36 level on atrial fibrillation and the subsequent catheter ablation. Heart Rhythm. 2011;8:650-656 (SCI)
  6. F.P. Chung, Y.F. Hu, T.F. Chao, S. Higa, H. Cheng, Y.J. Lin, S.L. Chang, L.W. Lo, T.C. Tuan, C.T. Tai, C.H. Li, Y.K. Lin, S.A. Chen*. The correlation between Ventricular Repolarization and Clinical Severity of Spinal Cord Injuries. Heart Rhythm. 2011;8:879-884. (SCI)
  7. S.Y. Huang, Y.J. Lin, H.M. Tsao, S.L. Chang, L.W. Lo, H.F. Hu, K. Suenari, Y.K. Lin, J.H. Huang, I.C. Chen, W.C. Ko, E.T. Ong, S.A. Chen*. The biatrial substrate properties in different types of paroxysmal atrial fibrillation. Heart Rhythm. 2011;8:961-967 (SCI)
  8. T.F. Chao, C.C. Cheng, W.S. Lin, H.M. Tsao, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, S.H. Liu, B. Hartono, T.J. Wu, S.A. Chen*. Associations among the CHADS(2) score, atrial substrate properties, and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Heart Rhythm. 2011;8:1155-1159. (SCI)
  9. T.F. Chao, Y.J. Lin, H.M. Tsao, C.F. Tsai, W.S. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, B. Hartono, H.Y. Chang, K. Ambrose, T.J. Wu, S.A. Chen*. CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011;58:2380-2385. (SCI)
  10. R. Cappato*, H. Calkins, S.A. Chen, W. Davies, Y. Iesaka, J. Kalman, Y.H. Kim, G. Klein, A. Natale, D. Packer, C. Ricci, A. Skanes, M. Ranucci. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011;58:2696-2697. (SCI)
  11. T.F. Chao, H.M. Tsao*, Y.J. Lin, C.F. Tsai, W.S. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, B. Hartono, H.Y. Chang, K. Ambrose, T.J. Wu, S.A. Chen*. Clinical outcome of catheter ablation in patients with nonparoxysmal atrial fibrillation: results of 3-year follow-up. Circ Arrhythm Electrophysiol. 2012;5:514-520. (SCI)
  12. Y.F. Hu, H.I. Yeh*, H.M. Tsao, C.T. Tai, Y.J. Lin, S.L. Chang, L.W. Lo, T.C. Tuan, K. Suenari, C.H. Li, T.F. Chao, S.A. Chen*. Electrophysiological correlation and prognostic impact of heat shock protein 27 in atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5:334-340. (SCI)
  13. T.F. Chao, C.J. Liu, S.J. Chen, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Wu, T.J. Chen, H.M. Tsao, S.A. Chen*. Atrial Fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke. 2012;43:2551-2555. (SCI)
  14. Y.J. Lin, K. Suenari, M.T. Lo, Lin C, W.H. Hsieh, S.L. Chang, L.W. Lo, Y.F. Hu, C.C. Cheng, Y. Kihara, T.F. Chao, B. Hartono, T.J. Wu, W.S. Lin, K.H. Hsu, A.S. Kibos, N.E. Huang, S.A. Chen*. Novel assessment of temporal variation in fractionated electrograms using histogram analysis of local fractionation interval in patients with persistent atrial fibrillation. Circ Arrhythm Electrophysiol. 2012;5:949-956. (SCI)
  15. T.F. Chao, K. Ambrose, H.M. Tsao, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, B. Hartono, H.Y. Chang, T.J. Wu, S.A. Chen*. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm. 2012;9:1185-1191. (SCI)
  16. T.F. Chao, H.M. Tsao, K. Ambrose, Y.J. Lin, W.S. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, K. Suenari, C.H. Li, B. Hartono, H.Y. Chang, F.P. Chung, D.A. Hanafy, W.Y. Lin, S.A. Chen*. Renal dysfunction and the risk of thromboembolic events in patients with atrial fibrillation after catheter ablation-The potential role beyond the CHA(2)DS(2)-VASc score. Heart Rhythm. 2012;9:1755-1760. (SCI)
  17. C.H. Wu, Y.F. Hu, C.Y. Chou, Y.J. Lin, S.L. Chang, L.W. Lo, T.C. Tuan, C.H. Li, T.F. Chao, F.P. Chung, J.N. Liao, S.A. Chen*. Transforming growth factor-ß(1) level and outcome after catheter ablation for non-paroxysmal atrial fibrillation. Heart Rhythm. 2013;10:10-15. (SCI)
  18. Y.J. Lin, M.T. Lo, C. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, W.H. Hsieh, H.Y. Chang, W.Y. Lin, F.P. Chung, J.N. Liao, Y.Y. Chen, D. Hanafy, N.E. Huang, S.A. Chen*. Prevalence, characteristics, mapping, and catheter ablation of potential rotors in non-paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6:851-858. (SCI)
  19. F.P. Chung, H.R. Li, E. Chong, C.H. Pan, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.F. Chao, J.N. Liao, W.Y. Lin, K.P. Shaw*, S.A. Chen*. Seasonal variation in the frequency of sudden cardiac death and ventricular tachyarrhythmia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy: the effect of meteorological factors. Heart Rhythm. 2013;10:1859-1866. (SCI)
  20. F.P. Chung, E. Chong, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.F. Chao, J.N. Liao, Y.C. Huang, P.C. Chi, C.S. Chan, Y.Y. Chen, H.K. Huang, S.A. Chen*. Different characteristics and electrophysiological properties between early and late recurrences after acute successful catheter ablation of idiopathic right ventricular outflow tract arrhythmias during long-term follow-up. Heart Rhythm. 2014;11:1760-1769. (SCI)
  21. T.F. Chao, C.J. Liu, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, F.P. Chung, J.N. Liao, T.J. Chen, G.Y. Lip, S.A. Chen*. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis. Heart Rhythm. 2014;11:1752-1759. (SCI)
  22. T.F. C hao, C.J. Liu, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, G.Y. Lip, S.A. Chen*. Using the CHA2DS2-VASc score for refining stroke risk stratification in 'low-risk' Asian patients with atrial fibrillation. J Am Coll Cardiol. 2014;64:1658-1665. (SCI)
  23. T.F. Chao, C.J. Liu, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, G.Y. Lip, S.A. Chen*. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol. 2015;65:635-642. (SCI)
  24. E. Chong, S.L. Chang, Y.W. Hsiao, R. Singhal, S.H. Liu, T. Leha, W.Y. Lin, C.P. Hsu, Y.C. Chen, Y.J. Chen, T.J. Wu, S. Higa, S.A. Chen*. Resveratrol, a red wine antioxidant, reduces atrial fibrillation susceptibility in the failing heart by PI3K/AKT/eNOS signaling pathway activation. Heart Rhythm. 2015;12:1046-56. (SCI)
  25. T.F. Chao, K.L. Wang, C.J. Liu, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, F.P. Chung, J.N. Liao, T.J. Chen, C.E. Chiang, G.Y. Lip, S.A. Chen*. Age threshold for increased stroke risk among patients with atrial fibrillation: A nationwide cohort study from Taiwan. J Am Coll Cardiol. 2015;66:1339-1347. (SCI)
  26. T.F. Chao, C.J. Liu, T.C. Tuan, S.J. Chen, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.J. Chen, C.E. Chiang*, S.A. Chen*. Rate-control treatment and mortality in atrial fibrillation. Circulation. 2015;132:1604-1612. (SCI)
  27. J.N. Liao, T.F. Chao, C.J. Liu, K.L. Wang, S.J. Chen, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, F.P. Chung, T.J. Chen, S.A. Chen*. Incidence and risk factors for new-onset atrial fibrillation among patients with end-stage renal disease undergoing renal replacement therapy. Kidney Int. 2015;87:1209-1215 (SCI)
  28. C.Y. Lin, Y.J. Lin, L.W. Lo, Y.Y. Chen, E. Chong, S.L. Chang, F.P. Chung, T.F. Chao, Y.F. Hu, T.C. Tuan, J.N. Liao, Y. Chang, K.L. Chien, C.W. Chiou, S.A. Chen*. Factors predisposing to ventricular proarrhythmia during antiarrhythmic drug therapy for atrial fibrillation in patients with structurally normal heart. Heart Rhythm. 2015;12:1490-1500. (SCI)
  29. T.F. Chao, Y.C. Huang, C.J. Liu, S.J. Chen, K.L. Wang, Y.J. Lin, S.L. Chang, L.W. Lo, Y.F. Hu, T.C. Tuan, T.J. Chen, M.H. Hsieh, G.Y. Lip, S.A. Chen*. Acute myocardial infarction in patients with atrial fibrillation with a CHA2DS2-VASc score of 0 or 1: A nationwide cohort study. Heart Rhythm. 2015;11:1941-1947.(SCI)
  30. Y.F. Hu, Y.J. Chen, Y.J. Lin, S.A. Chen*. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12:230-243. (SCI)